Cigna Corporation Q1 2026 Earnings Call Summary
Cigna reported strong performance in its Evernorth division driven by high demand for specialty drugs. The company is exiting non-core businesses and introducing a new pharmacy model to reduce drug costs, while also leveraging AI tools to improve efficiency.
Tickers: $CI
Topics: earnings healthcare leadership_transition operational_efficiency pharmacy_model strategic_positioning